| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Antivenom |
Is a |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Respiratory syncytial virus immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Clostridium botulinum product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Botulinum toxin type A 500 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Clostridium botulinum 100units powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| préparation d'antitoxine botulinique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| injection du vaccin d'anatoxine diphtérique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon d'une solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon d'une solution pour perfusion de 2500 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| poudre de 1000 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| poudre de 200 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| poudre de 500 UI d'immunoglobuline contre l'hépatite B pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| seringue préremplie avec solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Equine gamma globulin 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing rabbit anti-human T-lymphocyte globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Rabbit anti-human T-lymphocyte globulin 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| antitoxine diphtérique équine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing antivenom (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing Erysipelothrix rhusiopathiae antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing antiserum (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Product containing Salmonella typhimurium antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing Streptococcus equisimilis antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing Streptococcus suis antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Immune globulin IV |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Immune globulin IM |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing Escherichia coli antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing Escherichia coli antiserum and Pasteurella multocida antiserum and Salmonella typhimurium antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing gas gangrene antitoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Varicella-zoster virus antibody-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing lymphocyte immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| antisérum contre une maladie animale |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing diphtheria antitoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Tetanus antitoxin, human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| sérum d'immunoglobulines humaines |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Vaccinia human immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing rabies human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing botulinum antitoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing human tetanus immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing pertussis human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing poliomyelitis human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Hepatitis B surface antigen immunoglobulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Cytomegalovirus antibody-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Vaccines and antisera |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Anti-hbs immunoglobulin injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Antitetanus immunoglob. injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Anti-varicella-zoster ig injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing botulinum toxin type B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon de 1 unité d'immunoglobuline contre l'hépatite B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| immunoglobuline contre la rage de 150 UI/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon d'une solution injectable de 150 U d'immunoglobuline contre la rage |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon d'une solution injectable de 217 U d'immunoglobuline antihépatique B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Immune globulin + sodium chloride 1gm/0.9%wv injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing tetanus antitoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Clostridium botulinum B toxin 5000u/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Clostridium botulinum B toxin 5000u/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Clostridium botulinum B toxin 5000u/mL injection solution 0.5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Tetanus immune globulin huma 250units injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Tetanus immune globulin huma 250units injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Human vaccinia immune globulin 50mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing botulism immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Botulism immunoglobulin 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Antitoxin |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Adverse reaction caused by antiserum (disorder) |
Causative agent (attribute) |
True |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Antisera allergy |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Antisera overdose |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Accidental antisera overdose |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Intentional antisera overdose |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Antisera overdose of undetermined intent |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| flacon de 1 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| flacon de 5 mL d'une solution injectable de 312 unités/mL d'immunoglobuline contre l'hépatite B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| poudre de 125 UI d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Antisera poisoning |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Accidental antisera poisoning |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Intentional antisera poisoning |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Antisera poisoning of undetermined intent |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| poudre de 125 UI d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Respiratory syncytial virus immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Immune globulin + sodium chloride 1gm/0.9%wv injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing poliomyelitis human immune globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Human vaccinia immune globulin 50mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| sérum d'immunoglobulines humaines |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing lymphocyte immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Equine gamma globulin 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Vaccinia human immune globulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Product containing snake antivenom immunoglobulin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Antisera allergy |
Causative agent (attribute) |
False |
Antiserum (substance) |
Inferred relationship |
Some |
1 |
| Product containing Streptococcus equisimilis antiserum and Streptococcus suis antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Escherichia coli antiserum (substance) |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Salmonella typhimurium antiserum |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Streptococcus suis antiserum (substance) |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Streptococcus equisimilis antiserum |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Pasteurella multocida antiserum (substance) |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
| Erysipelothrix rhusiopathiae antiserum (substance) |
Is a |
True |
Antiserum (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]